Key clinical trials in gynaecological oncology

J Morrison; S Kehoe

doi:10.1016/j.ejso.2006.03.038

Key clinical trials in gynaecological oncology

J Morrison, S Kehoe

Cancer and Genomic Sciences

Research output: Contribution to journal › Article › peer-review

Abstract

AIMS: To review the most important clinical trials which have impacted the management of gynaecological cancers, in conjunction with some ongoing studies of interest.

METHODS: PubMed and Cochrane databases were searched to find clinical trials and meta-analyses in vulva, cervical, endometrial and ovarian cancers. Other pertinent literature was also used.

RESULTS: The majority of trials related to ovarian and cervical cancers, and the least associated with vulval cancer.

CONCLUSIONS: To ensure evidence based medicine, trials in gynaecological cancers must be supported. Notably, surgical trials are on the increase in the last decade, but are still a minority when compared with non-surgical interventions.

Original language	English
Pages (from-to)	887-91
Number of pages	5
Journal	European Journal of Surgical Oncology (EJSO)
Volume	32
Issue number	8
DOIs	https://doi.org/10.1016/j.ejso.2006.03.038
Publication status	Published - Oct 2006

Keywords

Clinical Trials as Topic
Female
Genital Neoplasms, Female
Gynecology
Humans
Medical Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejso.2006.03.038

Cite this

@article{91b3debae1524d75b6f2954328d8d9d5,

title = "Key clinical trials in gynaecological oncology",

abstract = "AIMS: To review the most important clinical trials which have impacted the management of gynaecological cancers, in conjunction with some ongoing studies of interest.METHODS: PubMed and Cochrane databases were searched to find clinical trials and meta-analyses in vulva, cervical, endometrial and ovarian cancers. Other pertinent literature was also used.RESULTS: The majority of trials related to ovarian and cervical cancers, and the least associated with vulval cancer.CONCLUSIONS: To ensure evidence based medicine, trials in gynaecological cancers must be supported. Notably, surgical trials are on the increase in the last decade, but are still a minority when compared with non-surgical interventions.",

keywords = "Clinical Trials as Topic, Female, Genital Neoplasms, Female, Gynecology, Humans, Medical Oncology",

author = "J Morrison and S Kehoe",

year = "2006",

month = oct,

doi = "10.1016/j.ejso.2006.03.038",

language = "English",

volume = "32",

pages = "887--91",

journal = "European Journal of Surgical Oncology (EJSO)",

issn = "0748-7983",

publisher = "Elsevier",

number = "8",

}

TY - JOUR

T1 - Key clinical trials in gynaecological oncology

AU - Morrison, J

AU - Kehoe, S

PY - 2006/10

Y1 - 2006/10

N2 - AIMS: To review the most important clinical trials which have impacted the management of gynaecological cancers, in conjunction with some ongoing studies of interest.METHODS: PubMed and Cochrane databases were searched to find clinical trials and meta-analyses in vulva, cervical, endometrial and ovarian cancers. Other pertinent literature was also used.RESULTS: The majority of trials related to ovarian and cervical cancers, and the least associated with vulval cancer.CONCLUSIONS: To ensure evidence based medicine, trials in gynaecological cancers must be supported. Notably, surgical trials are on the increase in the last decade, but are still a minority when compared with non-surgical interventions.

AB - AIMS: To review the most important clinical trials which have impacted the management of gynaecological cancers, in conjunction with some ongoing studies of interest.METHODS: PubMed and Cochrane databases were searched to find clinical trials and meta-analyses in vulva, cervical, endometrial and ovarian cancers. Other pertinent literature was also used.RESULTS: The majority of trials related to ovarian and cervical cancers, and the least associated with vulval cancer.CONCLUSIONS: To ensure evidence based medicine, trials in gynaecological cancers must be supported. Notably, surgical trials are on the increase in the last decade, but are still a minority when compared with non-surgical interventions.

KW - Clinical Trials as Topic

KW - Female

KW - Genital Neoplasms, Female

KW - Gynecology

KW - Humans

KW - Medical Oncology

U2 - 10.1016/j.ejso.2006.03.038

DO - 10.1016/j.ejso.2006.03.038

M3 - Article

C2 - 16677796

SN - 0748-7983

VL - 32

SP - 887

EP - 891

JO - European Journal of Surgical Oncology (EJSO)

JF - European Journal of Surgical Oncology (EJSO)

IS - 8

ER -

Key clinical trials in gynaecological oncology

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this